38.78
0.75%
0.29
After Hours:
38.62
-0.16
-0.41%
Surmodics Inc stock is traded at $38.78, with a volume of 95,627.
It is up +0.75% in the last 24 hours and down -2.14% over the past month.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
See More
Previous Close:
$38.49
Open:
$38.42
24h Volume:
95,627
Relative Volume:
0.49
Market Cap:
$549.14M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
-23.50
EPS:
-1.65
Net Cash Flow:
$9.86M
1W Performance:
-1.42%
1M Performance:
-2.14%
6M Performance:
+32.17%
1Y Performance:
+20.85%
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-13-23 | Upgrade | Needham | Hold → Buy |
Feb-13-23 | Downgrade | Needham | Buy → Hold |
Jul-23-20 | Upgrade | Needham | Hold → Buy |
Dec-11-19 | Downgrade | Needham | Buy → Hold |
Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
Aug-01-19 | Reiterated | Needham | Buy |
May-02-19 | Reiterated | Lake Street | Buy |
May-02-19 | Reiterated | Needham | Buy |
Feb-21-19 | Reiterated | Needham | Buy |
May-16-18 | Reiterated | Needham | Buy |
Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
Feb-28-18 | Reiterated | Lake Street | Buy |
Feb-28-18 | Initiated | Needham | Buy |
Jul-14-17 | Initiated | Lake Street | Buy |
Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
May-03-16 | Reiterated | Barrington Research | Outperform |
Aug-06-15 | Reiterated | Barrington Research | Outperform |
Mar-27-15 | Initiated | Dougherty & Company | Buy |
Feb-25-14 | Initiated | Laidlaw | Buy |
Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
Water Island Capital LLC Makes New $1.16 Million Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Disciplined Growth Investors Inc. MN Sells 78,609 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Short Interest Down 25.3% in September - MarketBeat
StockNews.com Begins Coverage on Surmodics (NASDAQ:SRDX) - MarketBeat
(SRDX) Trading Advice - Stock Traders Daily
Solar Stock Under Rs 50: Microcap Company Secures Rs 189 Crore Order, Stock Hits Upper Circuit – Complete Details Inside! - Dalal Street Investment Journal
Views of Wall Street’s Leading Experts on Summit Materials Inc - SETE News
Here's why Sumit Gupta is bullish on diagnostic sector - The Economic Times
Sagefield Capital LP Takes $2.35 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Summit Materials, Inc. (NYSE:SUM) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Scilex (NASDAQ:SCLX) and Prime Medicine (NYSE:PRME) Critical Analysis - Defense World
Dimensional Fund Advisors LP Cuts Position in Sterling Infrastructure, Inc. (NASDAQ:STRL) - Defense World
Dimensional Fund Advisors LP Cuts Stock Holdings in Summit Materials, Inc. (NYSE:SUM) - Defense World
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Renaissance Technologies LLC Acquires 28,990 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Sterling Construction stock soars to all-time high of $137.93 - Investing.com
Gardner Lewis Asset Management L P Buys New Shares in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
(SRDX) Investment Report - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Trium Capital LLP Takes $1.41 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research
Down -5.46% in 4 Weeks, Here's Why SurModics Looks Ripe for a Turnaround - Benzinga
Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround - Yahoo Finance
Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround - Nasdaq
Wolverine Asset Management LLC Buys Shares of 25,966 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Research Coverage Started at StockNews.com - MarketBeat
Versor Investments LP Makes New Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Sees Significant Decrease in Short Interest - MarketBeat
Bailard Inc. Makes New Investment in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Nisa Investment Advisors LLC - Defense World
Nisa Investment Advisors LLC Has $2.88 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by California State Teachers Retirement System - Defense World
Analysts Issue Forecasts for Surmodics, Inc.'s FY2024 Earnings (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. Expected to Earn FY2024 Earnings of ($0.47) Per Share (NASDAQ:SRDX) - Defense World
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World
Surmodics (STU:SU6) EV-to-Revenue : 4.62 (As of Aug. 18, 2024) - GuruFocus.com
SRDX (Surmodics) Momentum Rank : 10 (As of Aug. 18, 2024) - GuruFocus.com
SRDX (Surmodics) GF Value Rank : 5 (As of Aug. 18, 2024) - GuruFocus.com
SRDX (Surmodics) Profitability Rank : 6 (As of Jun. 2024) - GuruFocus.com
SRDX (Surmodics) 3-Year Book Growth Rate : -4.00% (As of Jun. 2024) - GuruFocus.com
Surmodics Inc (SRDX) Reports Fiscal Year 2023 Earnings Growth an - GuruFocus.com
SRDX (Surmodics) 3-Year EPS without NRI Growth Rate : 24.00% (As of Jun. 2024) - GuruFocus.com
Q1 2026 EPS Estimates for Surmodics, Inc. (NASDAQ:SRDX) Increased by Analyst - MarketBeat
SurModics (SRDX) Loses -6.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Surmodics (SRDX) Inks Group Purchasing Agreement With Premier - MSN
Investment Analysts’ Weekly Ratings Changes for Surmodics (SRDX) - Defense World
Surmodics faces FTC scrutiny in pending merger By Investing.com - Investing.com Australia
Analytical Lens: Exploring Surmodics, Inc. (SRDX)’s Financial Story Through Ratios - The Dwinnex
Surmodics shareholders approve merger with BCE Parent By Investing.com - Investing.com Canada
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):